Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

Research output: Contribution to journalComment/debate

Abstract

In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.

Original languageEnglish
Pages (from-to)431-432
Number of pages2
JournalInternational journal of hematology
Volume112
Issue number3
DOIs
Publication statusPublished - Sep 1 2020

All Science Journal Classification (ASJC) codes

  • Hematology

Fingerprint Dive into the research topics of 'Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)'. Together they form a unique fingerprint.

  • Cite this